These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9752091)

  • 1. [Neuropeptides in the treatment of sensorineural hypoacusis in children].
    Pudov VI; Grigor'eva IF; Atamanova NV; Boronev SA
    Vestn Otorinolaringol; 1998; (4):22-4. PubMed ID: 9752091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transcranial electrostimulation combined with dalargin ultraphonophoresis in the treatment of patients with chronic idiopathic eczema].
    Iakushkina NIu; Silina LV; Zav'ialov AV
    Vopr Kurortol Fizioter Lech Fiz Kult; 2005; (4):25-7. PubMed ID: 16149414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacophysiotherapy in combined treatment of neurosensory hypoacusis in the presence of circulatory disorders in the vertebral arteries].
    Starokha AV; Khandazhapova IuA; Soldatenko MV; Solodilov VIu; Davydov AV
    Vestn Otorinolaringol; 2007; (4):4-6. PubMed ID: 17828103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinico-physiologic aspects of the use of therapeutic electric stimulation of the acoustic nerves in patients with neurosensory hypoacusis].
    Shandurina AN; Logunov VIu
    Fiziol Cheloveka; 1993; 19(2):53-8. PubMed ID: 8514022
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antioxidants and hyperbaric oxygenation in the treatment of sensorineural hearing loss in children].
    Muminov AI; Khatamov ZhA; Masharipov RR
    Vestn Otorinolaringol; 2002; (5):33-4. PubMed ID: 12524962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The efficacy of using dalargin electrophoresis in the combined treatment of patients with ischemic heart disease].
    Ilaev TM; Ratner ZG
    Lik Sprava; 1998; (2):74-7. PubMed ID: 9670662
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role of betaserk in combined treatment of neurosensory hypoacusis and vestibulopathy in childhood].
    Chistiakova VR
    Vestn Otorinolaringol; 2004; (2):9-12. PubMed ID: 15111941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Energy metabolic changes in the cardiorespiratory system of patients with chronic bronchitis under the action of galvanization and dalargin electrophoresis on the area of the chest cavity].
    Mizin VI
    Vopr Kurortol Fizioter Lech Fiz Kult; 1995; (4):7-10. PubMed ID: 8779193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Microwave therapy in combined rehabilitation of children suffering from chronic neurosensory hypoacusis].
    Uzunova AN; Kofanov RV; Chernysh NN
    Vopr Kurortol Fizioter Lech Fiz Kult; 2005; (4):28-30. PubMed ID: 16149415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of combined treatment of sensorineural hearing loss with electrostimulation and polycatan].
    Lobzov MS
    Vestn Otorinolaringol; 1997; (1):40-1. PubMed ID: 9092168
    [No Abstract]   [Full Text] [Related]  

  • 11. [Electrophysical effects in combined treatment of neurosensory hypoacusis].
    Morenko VM; Enin IP
    Vestn Otorinolaringol; 2002; (1):11-4. PubMed ID: 11892384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Audioselective transcranial electrostimulation in combined therapy of patients with neurosensory hypoacusis].
    Belimova AA; Ponomarenko GN; Ianov IuK; Lebedev VP
    Vopr Kurortol Fizioter Lech Fiz Kult; 2005; (5):26-30. PubMed ID: 16318004
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of patients with chronic pancreatitis of alcoholic etiology by dalagrin and laser therapy of the blood].
    Bulychev VF; Vakhrushev IaM
    Klin Med (Mosk); 2000; 78(12):43-6. PubMed ID: 11210353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenetic aspects of treating patients with neurosensory hypoacusis].
    Samsonov FA
    Vestn Otorinolaringol; 2004; (4):33-5. PubMed ID: 15496838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Low-energy laser radiation in the combined treatment of sensorineural hearing loss and Menière's disease].
    Pal'chun VT; Lapchenko AS; Kadymova MI; Kucherov AG
    Vestn Otorinolaringol; 1996; (1):23-5. PubMed ID: 8714046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of synthetic neuropeptides in complex of surgical treatment of acute pancreatitis and its complication].
    Pobuts'kyĭ OO
    Klin Khir; 2002 Jan; (1):26-9. PubMed ID: 11944292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy.
    Rousselle C; Clair P; Smirnova M; Kolesnikov Y; Pasternak GW; Gac-Breton S; Rees AR; Scherrmann JM; Temsamani J
    J Pharmacol Exp Ther; 2003 Jul; 306(1):371-6. PubMed ID: 12682214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cerebral hemodynamics in patients with neurosensory hearing loss before and after magnetotherapy].
    Morenko VM; Enin IP
    Vestn Otorinolaringol; 2001; (4):10-2. PubMed ID: 11530469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of dalargin for treating duodenal peptic ulcer recurrences on an outpatient basis].
    Buglak NP; Grigorenko EI; Dudar' LV
    Lik Sprava; 1994; (7-8):121-3. PubMed ID: 7900332
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacological possibilities in treatment hypoacusis in children].
    Pruszewicz A; Obrebowski A; Woźnica B; Swidziński P
    Otolaryngol Pol; 1994; 48(1):63-6. PubMed ID: 7970765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.